These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24699873)

  • 21. Renal dysfunction among adult HIV/AIDS patients on antiretroviral therapy at a tertiary facility in Ghana.
    Obiri-Yeboah D; Awuku YA; Alofa W; Charwudzi A; Aniakwa-Bonsu E; Obboh E; Nsiah P
    BMC Nephrol; 2018 Nov; 19(1):333. PubMed ID: 30463531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.
    Reynes J; Cournil A; Peyriere H; Psomas C; Guiller E; Chatron M; Cristol JP; Badiou S
    AIDS; 2013 May; 27(8):1295-302. PubMed ID: 23925378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.
    Young B; Buchacz K; Moorman A; Wood KC; Brooks JT;
    AIDS Patient Care STDS; 2009 Aug; 23(8):589-92. PubMed ID: 19591609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection.
    Margolick JB; Jacobson LP; Schwartz GJ; Abraham AG; Darilay AT; Kingsley LA; Witt MD; Palella FJ
    PLoS One; 2014; 9(2):e86311. PubMed ID: 24516530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.
    Kalayjian RC; Franceschini N; Gupta SK; Szczech LA; Mupere E; Bosch RJ; Smurzynski M; Albert JM
    AIDS; 2008 Feb; 22(4):481-7. PubMed ID: 18301060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Highly Active Antiretroviral Therapy on Renal Function and Renal Phosphate Handling in African Adults with Advanced HIV and CKD.
    Adedeji TA; Adebisi SA; Adedeji NO; Biliaminu SA; Olanrewaju TO
    Infect Disord Drug Targets; 2019; 19(1):88-100. PubMed ID: 30027856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy.
    Biagi M; Badowski M; Chiampas T; Young J; Vaughn P; Shicker L; Patel M
    Int J STD AIDS; 2016 Aug; 27(9):808-11. PubMed ID: 26378193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
    Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
    Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
    Bonjoch A; Juega J; Puig J; Pérez-Alvarez N; Aiestarán A; Echeverría P; Pérez V; Clotet B; Romero R; Bonet J; Negredo E
    AIDS Patient Care STDS; 2014 Oct; 28(10):524-9. PubMed ID: 25238104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.
    Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Knobel H; Palacios R; Antela A; Blanco JR; Fulladosa X;
    Nefrologia (Engl Ed); 2019; 39(5):497-505. PubMed ID: 31027896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV and the kidney.
    Post FA; Hendry BM
    Br J Hosp Med (Lond); 2008 Mar; 69(3):137-40. PubMed ID: 18422216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
    Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
    Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.
    Jabłonowska E; Wójcik K; Piekarska A
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):363-9. PubMed ID: 24164392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda.
    Lucas GM; Clarke W; Kagaayi J; Atta MG; Fine DM; Laeyendecker O; Serwadda D; Chen M; Wawer MJ; Gray RH
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):491-4. PubMed ID: 20613548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals.
    Inker LA; Wyatt C; Creamer R; Hellinger J; Hotta M; Leppo M; Levey AS; Okparavero A; Graham H; Savage K; Schmid CH; Tighiouart H; Wallach F; Krishnasami Z
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):302-9. PubMed ID: 22842844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study.
    Viganò A; Zuccotti GV; Martelli L; Giacomet V; Cafarelli L; Borgonovo S; Beretta S; Rombolà G; Mora S
    Clin Drug Investig; 2007; 27(8):573-81. PubMed ID: 17638398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
    Mulenga L; Musonda P; Mwango A; Vinikoor MJ; Davies MA; Mweemba A; Calmy A; Stringer JS; Keiser O; Chi BH; Wandeler G;
    Clin Infect Dis; 2014 May; 58(10):1473-80. PubMed ID: 24585558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to manage HIV-infected patients with chronic kidney disease in the HAART era.
    Ando M; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2012 Jun; 16(3):363-72. PubMed ID: 22294158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of lean mass and bone density on glomerular filtration rate estimation in people living with HIV/AIDS.
    Isnard Bagnis C; Pieroni L; Inaoui R; Maksud P; Lallauret S; Valantin MA; Tubiana R; Katlama C; Deray G; Courbebaisse M; Tourret J; Tezenas du Montcel S
    PLoS One; 2017; 12(11):e0186410. PubMed ID: 29096403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.